Healthcare Services

De-Identified Health Data Market Future Outlook Showing Expansion Toward $16.07 Billion by 2030

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The De-Identified Health Data Market Over The Period 2026–2030?

The de-identified health data market size has shown rapid expansion in recent years. It is anticipated to increase from $9.2 billion in 2025 to $10.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.1%. The growth observed in prior periods can be attributed to the rising adoption of electronic health records, a surging demand for population health analytics, the expansion of clinical research databases, an intensified focus on patient privacy compliance, and the increasing availability of structured healthcare data.

The de-identified health data market size is anticipated to undergo significant expansion over the next few years. It is forecast to grow to $16.07 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 11.7%. The projected increase in this period can be attributed to the rising application of AI-driven health insights, greater investments in precision medicine research, the broadening scope of value-based care analytics, a heightened demand for secure health data exchange, and the increased adoption of real-world evidence in regulatory decisions. Notable developments in the forecast period include the proliferation of large-scale de-identified data platforms, expanded utilization of real-world evidence analytics, a growing need for privacy-preserving data sharing models, increased uptake of longitudinal patient data analysis, and the consolidation of multi-source healthcare datasets.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28191&type=smp

What Drivers Are Expected To Influence The De-Identified Health Data Market During The Forecast Period?

The expanding embrace of electronic health records (EHRs) is anticipated to fuel the expansion of the de-identified health data market going forward. EHRs represent a digital record of a patient’s complete medical history, encompassing diagnoses, treatments, medications, lab results, and other health information, which is securely stored and accessible to authorized healthcare providers. Their increasing use stems from their capacity to improve patient care and safety by providing precise, real-time access to extensive medical information. De-identified health data further enhances electronic health records by facilitating secure data sharing and sophisticated analytics while safeguarding patient privacy, ultimately leading to improved clinical choices and healthcare results. For instance, in August 2025, as per a 2024 report by the National Center for Biotechnology Information, a US-based National Library of Medicine (NLM), which is part of the U.S. National Institutes of Health (NIH) a federal government agency, the majority of hospitals had implemented patient engagement features allowing patients to electronically view (99%) (e.g., test results), download (96%), and transmit their health information to a third party (84%). Consequently, the growing adoption of electronic health records (EHRs) is propelling the growth of the de-identified health data market.

How Is The De-Identified Health Data Market Divided Into Its Major Segments?

The de-identified health data market covered in this report is segmented –

1) By Type: Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Hospital And Provider Data, Pharmacogenomic Data

2) By Application: Clinical Research And Trials, Public Health, Precision Medicine, Health Economics And Outcomes Research (HEOR), Population Health Management, Drug Discovery And Development, Healthcare Quality Improvement, Insurance Underwriting And Risk Assessment, Other Applications

3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Insurance Companies Or Healthcare Payers, Research Institutions, Government Agencies, Other End-Users

Subsegments:

1) By Clinical Data: Electronic Health Records, Medical Imaging Data, Laboratory Test Results, Surgical Reports, Pathology Reports, Vital Signs Measurements

2) By Genomic Data: Whole Genome Sequencing Data, Exome Sequencing Data, Single Nucleotide Polymorphism Data, Gene Expression Profiles, Epigenetic Data

3) By Patient Demographics: Age Information, Gender Information, Ethnicity Information, Geographic Location, Socioeconomic Status, Marital Status

4) By Prescription Data: Medication Orders, Dosage Information, Prescription Refill History, Drug Allergies, Pharmacy Dispensation Records

5) By Hospital And Provider Data: Provider Performance Metrics, Care Delivery Outcomes, Billing And Claims Data, Resource Utilization Data

6) By Pharmacogenomic Data: Gene–Drug Interaction Data, Adverse Drug Reaction Data, Personalized Therapy Response Data, Drug Efficacy Variation Data

What Major Market Trends Are Driving Changes In The De-Identified Health Data Market?

Leading firms within the de-identified health data market are concentrating on creating sophisticated solutions, like real-world biomarker coverage applications, to facilitate evidence-based healthcare choices. Such an application utilizes de-identified patient information to observe and evaluate biomarker patterns and their efficacy among varied populations beyond traditional clinical trials, thus empowering researchers and healthcare providers with understanding regarding treatment outcomes and disease trajectories. For instance, in July 2025, Datma Inc., a US-based healthcare technology firm, introduced the Federated Biomarker Explorer. This free application is specifically designed for pharmaceutical teams to rapidly confirm real-world biomarker coverage across Datma’s collaborative network of contributing data partners. The tool furnishes aggregate, cohort-level insights into the presence of biomarkers, allowing for quick assessments without requiring contracts or IT assistance. Furthermore, it permits secure integration of users’ proprietary data for overlap analysis and supports early-stage feasibility evaluations through clinical and demographic filtering, aiding in verifying if datasets encompass the requisite patient populations prior to resource allocation.

Who Are The Prominent Organizations Shaping The De-Identified Health Data Market?

Major companies operating in the de-identified health data market are UnitedHealth Group Incorporated, Oracle Corporation, IQVIA Holdings Inc, ICON Public Limited Company, Datavant Inc, Premier Inc., iMerit Technology Services Pvt. Ltd., Tempus Labs Inc., Medidata Solutions Inc., Veradigm Inc., Flatiron Health, Merative LP, Komodo Health Inc., Shaip Inc., Truveta Inc., Evidation Health Inc., TriNetX Inc., Clarify Health Solutions Inc., Akrivia Health Ltd., Gradient Health Inc.

Read the full de-identified health data market report here:

https://www.thebusinessresearchcompany.com/report/de-identified-health-data-global-market-report

Which Region Is Forecast To Lead The De-Identified Health Data Market In Terms Of Market Size?

North America was the largest region in the de-identified health data market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the de-identified health data market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored De-Identified Health Data Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28191&type=smp

Browse Through More Reports Similar to the Global De-Identified Health Data Market 2026, By The Business Research Company

Heat Shrink Tubing And Sleeves Global Market Report

https://www.thebusinessresearchcompany.com/report/heat-shrink-tubing-and-sleeves-global-market-report

High Temperature Insulation Global Market Report

https://www.thebusinessresearchcompany.com/report/high-temperature-insulation-global-market-report

Thermal Paper Global Market Report

https://www.thebusinessresearchcompany.com/report/thermal-paper-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795